At the Head Office, PT Kimia Farma (Persero) Tbk conduct agreement signing BOT (Build Operate Transfer) with PT Brawijaya Investama for Construction of Hospital Jalan Dr Saharjo - Jakarta.

This is done in the context of optimizing the Company's assets in several locations with a partner without losing the core business of the Company.

The signing of the cooperation carried out by the Development Director of PT Kimia Farma (Persero) Tbk, Pujianto and President Director of PT Brawijaya Investama, Amira Ganis and witnessed by President Commissioner and President Director of PT Kimia Farma (Persero) Tbk and the Board of Commissioners and Directors PT Brawijaya Investama. Selection PT Brawijaya Investama as a business partner because the hospital has experienced in the business so that future Hospital Hospital Road Saharjo can be professionally managed and is expected to be a learning process for Kimia Farma in developing and managing the Hospital

Hospital Building Project Jalan Dr Saharjo on a land area of ​​4.520m2 Company is located at Jalan Dr Saharjo No. 99 South Jakarta, will be built 8 floors and a capacity of 82 rooms hospitalization. Targeted construction of the building will be completed in 2019 with facilities Polyclinic, High Care Unit (HCU), Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), Intensive Care Unit (ICU), Radiology, Clinical Laboratory and also the construction of Pharmacy Kimia Farma in the building that will provide health services to the community and the added value in facilitating access to medical services


grafik KAEF.JK
2.390 (+1,70%)
Prev Close : 2.350
Volume : 31.800
BPOMLogo Badan POM kemenbumnlogo Kementerian BUMN
Kemenkeslogo Kementerian Kesehatan beilogo PT. Bursa Efek Jakarta